MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Risk of cancer in Parkinsons’s disease: a systematic review of diagnostic validity

    A. Mehdiyeva, V. Kaasinen, J. Mauri, J. Sipilä (Joensuu, Finland)

    Objective: We systematically reviewed studies to investigate a possible association between validated PD diagnoses and cancer risk. Background: An inverse association between Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Direct Costs of patients with Parkinson’s Disease in a region of the Brazilian Amazon

    R. Feio, T. França, A. Passos, A. Silva, A. Escudeiro, B. Koshimoto, D. Moura, B. Lobato (Belém, Brazil)

    Objective: To evaluate the perception of the annual direct costs (medications, medical appointments, rehabilitation, transportation) associated with the treatment for patients with PD in the…
  • MDS Virtual Congress 2021

    Alpha-synuclein oligomers detection by proximity ligation assay in skin biopsy is a biomarker for Parkinson’s disease

    E. Vacchi, C. Senese, S. Pinton, A. Kaelin-Lang, G. Melli (Lugano, Switzerland)

    Objective: To assess the presence of oligomeric alpha-synuclein (αSyn), an early pathogenic species, in skin nerve fibers of patients with Parkinson’s disease (PD) and atypical…
  • MDS Virtual Congress 2021

    Evaluating Patients’ Preferences for Parkinson’s Disease Treatments

    M. Serbin, J. Sutphin, C. Leach, C. Mansfield, C. Yonan, O. Klepitskaya, M. Sheehan, A. Donnelly (San Diego, USA)

    Objective: To identify patients’ preferences for attributes of oral medications that are added to levodopa or levodopa/carbidopa (LD/CD) regimens to reduce OFF-time for Parkinson’s disease…
  • MDS Virtual Congress 2021

    PSYCHODYNAMIC THERAPY GROUPS FOR RELATIVES AND CAREGIVERS IN THE CONTEXT OF A PD PROGRAM

    L. Aguerre, E. Cortinas, M. Martinovic, G. Montado (Montevideo, Uruguay)

    Objective: Evaluate outcome of psychodynamic-oriented psychological support for relatives and caregivers in an Interdisciplinary program for non-pharmacological treatment with PD. Background: From the beginning of…
  • MDS Virtual Congress 2021

    Identifying and Controlling Variability in Digital Health Measures in Parkinson’s disease Clinical Trials

    G. Roussos, R. Bhatnagar, J. Burton, J. Cosman, A. Derungs, A. Dowling, K. Fisher, D. Hill, K. Praneeth Kilambi, L. Evers, N. Mehrotra, M. Minchik, M. Muller, T. Ruiz Herrero, S. Sardar, D. Stephenson (London, United Kingdom)

    Objective: The 3DT initiative of the Critical Path for Parkinson’s Consortium (CPP) aims to advance the regulatory maturity of digital biomarkers, for clinical studies in…
  • MDS Virtual Congress 2021

    Movement disorders in demyelination: A case series of ten patients

    R. Singh, S. Pandey (New Delhi, India)

    Objective: To observe the association of various movement disorder with demyelinating disease. Background: Movement disorders in demyelinating diseases are not an unheard entity, but besides…
  • MDS Virtual Congress 2021

    Progressive encephalomyelitis with rigidity and myoclonus in a Mexican patient

    R. Garcia-Bermudez, D. Leon-Castillo, B. Bertado-Cortes (Mexico City, Mexico)

    Objective: To present a case report of a Mexican patient with a progressive encephalomyelitis with rigidity and myoclonus (PERM) with a good response to steroids.…
  • MDS Virtual Congress 2021

    Patterns of Improvement with Valbenazine in Patients with Tardive Dyskinesia

    C. Correll, T. Carmack, C. Shah, L. Lundt (Glen Oaks, USA)

    Objective: To characterize different patterns of improvement with valbenazine (VBZ) in patients with tardive dyskinesia (TD) using Abnormal Involuntary Movement Scale (AIMS) data from KINECT…
  • MDS Virtual Congress 2021

    An International Pre-Implementation Survey To Assess The Acceptability Of Telemedicine As An Alternative To In-Person Clinic Consultations For PD

    O. Ojo, JH. Ahn, Z. Aldaajani, J. Bajwa, A. Bustillo, A. Cardozo, M. Dekker, E. Eldayem, Z. Mari, A. Shalash, M. Shackleford, M. Spindler, J. Youn, E. Cubo, N. Okubadejo (Idi-Araba, Nigeria)

    Objective: To assess the acceptability of virtual consultations as an option for out-patient clinic consultations for PD Background: The practice of telemedicine increased dramatically on…
  • « Previous Page
  • 1
  • …
  • 728
  • 729
  • 730
  • 731
  • 732
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley